Hematology

A recent retrospective study has shed new light on the effectiveness of chimeric antigen receptor T cell therapy for patients with transformed indolent non-Hodgkin lymphoma….

A recent study has introduced FlowScore, a new metric for evaluating the quality of red blood cells that goes beyond traditional haemoglobin assays…

A new study highlights the link between visit-to-visit blood pressure variability (BPV) and cognitive decline in older adults….

This phase 1–2, randomised, double-blind, placebo-controlled trial enrolled 130 patients aged 18 or older with confirmed sickle cell disease.

In a phase 3 trial involving 44 patients aged 12 to 35, exa-cel was found to provide remarkable results….

A recent multicentre study has shown that venetoclax combined with decitabine as an effective first-line treatment for older patients with acute myeloid leukaemia.

A groundbreaking study has developed a blood-based ageing clock capable of predicting biological age and providing insights into the ageing process…

A phase 3 clinical trial, explorer8, has demonstrated the efficacy and safety of concizumab…